SEC Form D · filed February 17, 2021
Cyteir Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (26)
Jean George · LEXINGTON, MADirectorRacquel Bracken · LEXINGTON, MADirectorJanwillem Naesens · LEXINGTON, MADirectorKaren Hong · LEXINGTON, MADirectorTimothy S. Romberger · LEXINGTON, MADirectorMarkus Renschler · LEXINGTON, MAExec · DirectorJoseph S. Zakrzewski · LEXINGTON, MADirectorFrank G. Haluska · Wayland, MADirectorCarson R. Noel · St. John's, Newfoundland and Labrador, CanadaDirectorFraser R. Edison · St. John's, Newfoundland and Labrador, CanadaDirectorJohn R. Anderson · St. John's, Newfoundland and Labrador, CanadaDirectorBrian Hardecker · Long Island City, NYExec · DirectorEnrico Scolari · San Diego, CADirectorPaul S. Secrist · LEXINGTON, MAExecAndrew S. Gengos · LEXINGTON, MAExecSusan S. Molineaux · LEXINGTON, MADirectorCarl Schoellhammer · Cambridge, MADirectorRobert Langer · Cambridge, MADirectorAndrew Klaber · New York, NYDirectorInvestment Advisor Pgim Limited · Newark, NJExec · DirectorMatthew Schutzman · Munster, INDirectorZak Nugent · Cottonwood Heights, X1DirectorPaul S. Secrist · LEXINGTON, MAExecAndrew S. Gengos · LEXINGTON, MAExecSusan S. Molineaux · LEXINGTON, MADirectorJoseph S. Zakrzewski · LEXINGTON, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗